228 research outputs found

    Particle-antiparticle asymmetries from annihilations

    Get PDF
    An extensively studied mechanism to create particle-antiparticle asymmetries is the out-of-equilibrium and CP violating decay of a heavy particle. Here we instead examine how asymmetries can arise purely from 2 2 annihilations rather than from the usual 1 2 decays and inverse decays. We review the general conditions on the reaction rates that arise from S-matrix unitarity and CPT invariance, and show how these are implemented in the context of a simple toy model. We formulate the Boltzmann equations for this model, and present an example solution.Comment: 5 pages, v2: added reference, v3: some changes to text in response to comment

    Lifetime Constraints for Late Dark Matter Decay

    Full text link
    We consider a class of late-decaying dark-matter models, in which a dark matter particle decays to a heavy stable daughter of approximately the same mass, together with one or more relativistic particles which carry away only a small fraction of the parent rest mass. Such decays can affect galactic halo structure and evolution, and have been invoked as a remedy to some of the small scale structure-formation problems of cold dark matter. There are existing stringent limits on the dark matter lifetime if the decays produce photons. By considering examples in which the relativistic decay products instead consist of neutrinos or electron-position pairs, we derive stringent limits on these scenarios for a wide range of dark matter masses. We thus eliminate a sizable portion of the parameter space for these late decay models if the dominant decay channel involves Standard Model final states.Comment: 13 pages, 7 figures. Replaced to match published version. Discussion expanded. References added. Accepted by Phys. Rev

    Dark Matter's secret liaisons: Phenomenology of a dark U(1) sector with bound states

    Get PDF
    Dark matter (DM) charged under a dark U(1) force appears in many extensions of the Standard Model, and has been invoked to explain anomalies in cosmic-ray data, as well as a self-interacting DM candidate. In this paper, we perform a comprehensive phenomenological analysis of such a model, assuming that the DM abundance arises from the thermal freeze-out of the dark interactions. We include, for the first time, bound-state effects both in the DM production and in the indirect detection signals, and quantify their importance for Fermi, Ams-02, and CMB experiments. We find that DM in the mass range 1 GeV to 100TeV, annihilating into dark photons of MeV to GeV mass, is in conict with observations. Instead, DM annihilation into heavier dark photons is viable. We point out that the late decays of multi-GeV dark photons can produce significant entropy and thus dilute the DM density. This can lower considerably the dark coupling needed to obtain the DM abundance, and in turn relax the existing constraints

    Final-state interactions in the response of nuclear matter

    Get PDF
    Final-state interactions in the response of a many-body system to an external probe delivering large momentum are normally described using the eikonal approximation, for the trajectory of the struck particle, and the frozen approximation, for the positions of the spectators. We propose a generalization of this scheme, in which the initial momentum of the struck particle is explicitly taken into account. Numerical calculations of the nuclear matter response at 1 <∣q∣<< |{\bf q}| < 2 GeV/c show that the inclusion of this momentum dependence leads to a sizable effect in the low energy tail. Possible implications for the analysis of existing electron-nucleus scattering data are discussed.Comment: 21 pages, 4 figure

    Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma

    Get PDF
    Kallikreins play an important role in tumour microenvironment and as cancer biomarkers in different cancer entities. Previous studies suggested an upregulation of KLK10 and KLK6 in pancreatic ductal adenocarcinoma (PDAC). Therefore, we evaluated the clinicopathological role of these kallikreins and their value as biomarkers in PDAC
    • …
    corecore